Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar, Angela Dispenzieri, Morie A. Gertz, Shaji Kumar, Francis K. Buadi, Nelson Leung, Martha Q. Lacy, David Dingli, Sikander Ailawadhi, P. Leif Bergsagel, Rafaël Fonseca, Suzanne R. Hayman, Prashant Kapoor, Martha Grogan, Omar F. Abou Ezzeddine, Julie Rosenthal, Michelle L. Mauermann, Mustaqueem Siddiqui, Wilson I. Gonsalves, Taxiarchis Kourelis, Jeremy T. Larsen, Craig B. Reeder, Rahma Warsame, Ronald S. Go, David Murray, Ellen D. McPhail, Surendra Dasari, Dragan Jevremović, Robert A. Kyle, Yi Lin, John A. Lust, Stephen J. Russell, Yi L. Hwa, Amie Fonder, Miriam Hobbs, S. Vincent Rajkumar, Vivek Roy, Taimur Sher
Topics & Concepts
MedicineAL amyloidosisAmyloidosisOrgan dysfunctionIntensive care medicineMultiple myelomaInternal medicineImmunologyImmunoglobulin light chainAntibodySepsisAmyloidosis: Diagnosis, Treatment, OutcomesMyeloproliferative Neoplasms: Diagnosis and TreatmentDrug Transport and Resistance Mechanisms